Frontlight ResearchEarly access
CompletedNo phase
Evaluate the Benefit of an Individualised Treatment Plan (VitalCare) VS SOC in OSA Patients Treated With CPAP/APAP
Key facts
- Who runs it
- Air Liquide Santé International
- Where
- Portugal1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 113 people enrolled
- Started
- 15 Feb 2022
- Ended
- 30 Jun 2024
- Type of study
- Interventional, 2 groupsOne group gets no study treatment, for comparison.
- Treatments tested
- individualised treatment plan (VitalCare) and associated remote medical monitoring
- Record updated
- 10 September 2025
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 14 criteriaShow less
Who can take part
- Patient diagnosed with Obstructive Sleep Apnoea Syndrome (OSAS) who is newly prescribed CPAP or APAP therapy at inclusion
- Patient agreeing to the collection of data from their CPAP/APAP device via teletransmission
- Patient equipped with a device compatible with the ResMed telemonitoring data platform
- Patient who has signed the informed consent form for the study
Who cannot take part
- Previous CPAP/APAP treatment for Sleep Apnoea
- Patient with ongoing Mandibular Advancement Device (MAD) or in the 12 previous months
- Patient participating in another drug or device study within the previous 30 days
- Patient at risk of other sleep disorders (e.g. severe insomnia)
- Patient with severe Chronic Heart Failure (NYHA stage III or IV)
- Obese patient presenting hypoventilation
- Patient with physical, mental or cognitive inability to use all components of the remote medical monitoring project and individualised treatment plan, as determined by the investigator wishing to include the patient
- Patient with severe COPD (FEV1 ≤ 50% predicted or modified Medical Research Council (mMRC) dyspnoea scale > 2)
- Patient's refusal of CPAP/APAP treatment support
- Patient with no permanent place of residence
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
According to a stratification procedure, the objective of a personalised care plan (VitalCare) is to identify points for improvement since the early stage of the patient's pathway of CPAP/APAP treatment and to adjust patient follow-up .
The 2 groups in the trial
- Standard of care groupNo study treatment, for comparison
with patients starting their regular CPAP/APAP treatment without stratification, with medical follow-up, and with standard home CPAP/APAP service provided by home healthcare,
- VitalCare groupTreatment being tested
with patients starting their CPAP/APAP treatment and with a personalized follow-up by the homecare provider.
Treatment: individualised treatment plan (VitalCare) and associated remote medical monitoring
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Multi-centre, National, Randomised, Exploratory Study Evaluating the Benefit of an Individualised Treatment Plan(VitalCare) Compared to Standard of Care, in Obstructive Sleep Apnoea Patients Treated With CPAP/APAP
- Record updated
- 10 September 2025